SERP
Comments:
SGC-AAK1-1 is a clean in vitro tool compound with decent biochemical potency, weak but selective cellular active. The upside of this compound is its kinome selectivity. The downside is its relatively modest cellular potency and lack of in vivo exposure. Investigators interested in AAK1 should also consider using BMT-090605, LP-935509, or BMS-986176/LX-9211, which are 3 literature compounds from different scaffolds and all commercially available (e.g., MedChemExpress). BMS-986176/LX-9211 in particular has reported kinome selectivity, exquisite potency, and good in vivo exposure. As a side note, LX9211 has been reported to show positive benefits in clinical trial for diabetic neuropathic pain. Combined use of multiple probes is recommended to avoid off-target effects.
(last updated:
8 Feb 2023 )